Moffitt Cancer Center experts are available for interviews
Tampa, FL—The Great American Smokeout, a campaign begun in 1976 to encourage smokers to quit for one day, is geared toward the more than 45 million smokers in the United States.
If you’re interested in participating in the Great American Smokeout on Nov. 20, Moffitt Cancer Center’s Tobacco Research and Intervention Program is a valuable resource. The FreshBreak™ Smoking Cessation Clinic offers free and low-cost smoking cessation programs. TRIP also is seeking participants to enroll in ongoing studies of smokers.
TRIP Director Thomas H. Brandon, Ph.D., is looking for participants in a study of how the smoking cessation medication varenicline affects how smokers think about and respond to smoking. The “Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement” study is not a treatment program for quitting smoking. Call (813) 745-4376 to see if you are eligible.
You can reach the TRIP office at (813) 745-1751.
Moffitt has several experts available for interviews regarding the Great American Smokeout, including Brandon; Dr. Gerold Bepler, program leader of Thoracic Oncology; and David J. Drobes, Ph.D.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida, Moffitt Cancer Center is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of “America’s Best Hospitals” for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.